ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts9999
Avg. Estimate-0.6-0.47-2.19-0.04
Low estimate-0.73-0.63-2.7-1.71
High estimate-0.47-0.34-1.732.45
Year ago EPS-1.05-0.81-3.52-2.19
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts9999
Avg. Estimate26M32.01M121.63M365.91M
Low estimate19.77M25.42M102.26M150.1M
High estimate36.08M46.06M164.67M692.7M
Year ago sales18.84M19.91M75.47M121.63M
Sales growth (year/est)38.00%60.80%61.20%200.80%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.93-0.92-0.84-0.65
Actual EPS-1.05-0.81-0.76-0.79
Difference-0.120.110.08-0.14
Surprise %-12.90%12.00%9.50%-21.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.6-0.47-2.19-0.04
7 days ago-0.6-0.47-2.19-0.04
30 days ago-0.58-0.5-2.240.02
60 days ago-0.61-0.51-2.280.2
90 days ago-0.58-0.51-2.161.48
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days5643
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.42.90%N/AN/AN/A
Next qtr.42.00%N/AN/AN/A
Current year37.80%N/AN/AN/A
Next year98.20%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A